Down-regulated expression of prostasin in high-grade or hormone-refractory human prostate cancers

Prostate

Volumn 54, Issue 3, 2003, Pages 187-193

  Takahashi, Satoru ^a,f   Suzuki, Shugo ^a   Inaguma, Shingo ^a   Ikeda, Yoshihisa ^a   Cho, Young Man ^a   Hayashi, Norio ^b   Inoue, Takahiro ^b   Sugimura, Yoshiki ^b   Nishiyama, Naoki ^c   Fujita, Tamio ^c   Chao, Julie ^d   Ushijima, Toshikazu ^e   Shirai, Tomoyuki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c Nagoya Memorial Hospital   (Japan)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^f NONE   (Japan)

Author keywords

Prostasin; Prostate cancer; Tumor progression

Indexed keywords

PROSTASIN; PROSTATE PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER GRADING; CONTROLLED STUDY; GENE; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; NORTHERN BLOTTING; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATE HYPERTROPHY; TUMOR GROWTH;

ADENOCARCINOMA; ANTIBODY SPECIFICITY; DNA, COMPLEMENTARY; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROSTATIC NEOPLASMS; RNA, MESSENGER; SERINE ENDOPEPTIDASES; TUMOR MARKERS, BIOLOGICAL;

EID: 0037441314     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10178     Document Type: Article

References (16)

1. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. 1997. Cancer incidence in five continents. Vol. VII, IARC Scientific Publications. Vol. 143. International Agency for Research on Cancer, Lyon.
2. Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM, Higgins SJ, Sugimura Y. The endocrinology and developmental biology of the prostate. Endocrinol Rev 1987;8:338-362.
3. Gaddipati JP, McLeod DG, Heidenberg HB, Sesterhenn IA, Finger MJ, Moul JW, Srivastava S. Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers. Cancer Res 1994;54:2861-2864.
4. Taplin M-E, Bubley GJ, Shuster TD, Frantz ME, Spooner AE, Ogata GK, Keer HN, Balk SP. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med 1995;332:1393-1398.
5. Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinanen R, Palmberg C, Palotie A, Tammela T, Isola J, Kallioniemi O-P. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet 1995;9:401-406.
6. Miyamoto H, Yeh S, Wilding G, Chang C. Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells. Proc Natl Acad Sci USA 1998;95:7379-7384.
7. Craft N, Shostak Y, Carey M, Sawyers CL. A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase. Nat Med 1999;5:280-285.
8. Hubank M, Schatz DG. Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res 1994;22:5640-5648.
9. Takahashi S, Suzuki S, Inaguma S, Cho Y-M, Ikeda Y, Hayashi N, Inoue T, Sugimura Y, Nishiyama N, Fujita T, Ushijima T, Shirai T. Down-regulation of Lsml is involved in human prostate cancer progression. Brit J Cancer 2002;86:940-946.
10. Yu JX, Chao L, Chao J. Prostasin is a novel human serine protease from seminal fluid. Purification, tissue distribution, and localization in prostate gland. J Biol Chem 1994;269:18843-18848.
11. Jiang YH, Davidson LA, Lupton JR, Chapkin RS. A rapid RT-PCR method for detection of intact RNA in formalin-fixed paraffin-embedded tissues. Nucleic Acids Res 1995;23:3071-3072.
12. Yu JX, Chao L, Ward DC, Chao J. Structural and chromosomal localization of the human prostasin (PRSS8) gene. Genomics 1996;32:334-340.
13. Ercolani L, Florence B, Denaro M, Alexander M. Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J Biol Chem 1988;263:15335-15341.
14. Visakorpi T, Kallioniemi AH, Syvanen AC, Hyytinen ER, Karhu R, Tammela T, Isola JJ, Kallioniemi OP. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 1995;55:342-347.
15. Crundwell MC, Chughtai S, Knowles M, Takle L, Luscombe M, Neoptolemos JP, Morton DG, Phillips SMA. Allelic loss on chromosomes 8p, 22q and 18q (DCC) in human prostate cancer. Int J Cancer (Pred Oncol) 1996;69:295-300.
16. Chen LM, Hodge GB, Guarda LA, Welch JL, Greenberg NM, Chai KX. Down-regulation of prostasin serine protease: A potential invasion suppressor in prostate cancer. Prostate 2001;48:93-103.